We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.66%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$209M
AUM Growth
-$220M
(-51%)
Cap. Flow
-$230M
Cap. Flow
% of AUM
-109.99%
Top 10 Holdings %
Top 10 Hldgs %
69.75%
Holding
27
New
–
Increased
–
Reduced
4
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$89.3M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$70.4M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$63.7M |
| 4 |
Gilead Sciences
GILD
|
+$3.25M |
| 5 |
K
Kellanova
K
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.09% |
| 2 | Technology | 11.3% |
| 3 | Financials | 10.87% |
| 4 | Communication Services | 5.26% |
| 5 | Consumer Staples | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| $75.3M | 36.02% |
1,755,000
-1,500,000
| -46% | -$63.7M |
|
|
SWI
2
DELISTED
SolarWinds Corporation Common Stock
SWI
| $9.63M | 4.6% |
497,561
-28,669
| -5% | -$564K |
|
3
Thermo Fisher Scientific
TMO
$220B
| $8.81M | 4.21% |
30,000
| – | – |
|
4
Toyota
TM
$225B
| $8.68M | 4.15% |
70,000
| – | – |
|
5
Sony
SONY
$138B
| $8.12M | 3.88% |
775,000
| – | – |
|
6
Hershey
HSY
$36.6B
| $8.04M | 3.85% |
60,000
| – | – |
|
7
Visa
V
$677B
| $7.81M | 3.74% |
45,000
| – | – |
|
8
Hilton Worldwide
HLT
$71.5B
| $7.33M | 3.51% |
75,000
| – | – |
|
9
American Tower
AMT
$80.4B
| $6.13M | 2.93% |
30,000
| – | – |
|
10
Expedia Group
EXPE
$37.3B
| $5.99M | 2.86% |
45,000
| – | – |
|
11
TSMC
TSM
$2.18T
| $5.88M | 2.81% |
150,000
| – | – |
|
12
Walt Disney
DIS
$181B
| $5.59M | 2.67% |
40,000
| – | – |
|
13
Alphabet (Google) Class C
GOOG
$4.32T
| $5.41M | 2.59% |
100,000
| – | – |
|
14
Mastercard
MA
$493B
| $5.29M | 2.53% |
20,000
| – | – |
|
15
Citigroup
C
$226B
| $5.25M | 2.51% |
75,000
| – | – |
|
|
CHL
16
DELISTED
China Mobile Limited
CHL
| $5.21M | 2.49% |
115,000
| – | – |
|
17
McDonald's
MCD
$195B
| $5.19M | 2.48% |
25,000
| – | – |
|
|
18
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $4.98M | 2.38% |
17,000
-310,000
| -95% | -$89.3M |
|
19
Deere & Co
DE
$168B
| $4.97M | 2.38% |
30,000
| – | – |
|
20
Amazon
AMZN
$2.96T
| $4.73M | 2.26% |
50,000
| – | – |
|
21
Morgan Stanley
MS
$340B
| $4.38M | 2.1% |
100,000
| – | – |
|
22
Costco
COST
$420B
| $2.64M | 1.26% |
10,000
| – | – |
|
|
23
iShares MSCI EAFE ETF
EFA
$80.2B
| $1.91M | 0.91% |
29,000
-1,075,000
| -97% | -$70.4M |
|
24
MakeMyTrip
MMYT
$5.64B
| $1.73M | 0.83% |
69,680
| – | – |
|
|
DVAX
25
DELISTED
Dynavax Technologies
DVAX
| $85K | 0.04% |
21,355
| – | – |
|
Similar funds
VM
SCP
SSC
I
SCMS
ACM
MCM
MIA
Howard Hughes Medical Institute's Q2 2019 Portfolio in Review
As of Q2 2019, Howard Hughes Medical Institute held 27 positions worth $209M, down 51% from $429M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Howard Hughes Medical Institute withdrew a net $230M in Q2 2019, closing 2 positions and reducing 4 holdings. Its most notable exit was Gilead Sciences, an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 7.2% a quarter earlier, followed by Technology and Financials.
- Howard Hughes Medical Institute's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $89.3M.
- Howard Hughes Medical Institute fully exited Gilead Sciences in Q2 2019, selling an estimated $3.25M.
- Howard Hughes Medical Institute's ten largest holdings make up 70% of its $209M portfolio in Q2 2019.
- Howard Hughes Medical Institute opened 0 new positions and closed 2 in Q2 2019.
- Howard Hughes Medical Institute's portfolio value fell 51% quarter-over-quarter to $209M.
Based on Howard Hughes Medical Institute's 13F filing for Q2 2019, filed 9 Aug 2019.